Production and biological evaluation of [18F]-6-thia-14-fluoro-heptadecanoic acid

Amir R. Jalilian et al.

Vol 9, No 2 (2006)

Submitted: 2012-01-23

Published online: 2006-06-21

View PDF

Download PDF file

Get Citation

Production and biological evaluation of [18F]-6-thia-14-fluoro-heptadecanoic acid

Amir R. Jalilian et al.

Nucl. Med. Rev 2006;9(2):108-113.

Vol 9, No 2 (2006)

Submitted: 2012-01-23

Published online: 2006-06-21

Abstract

BACKGROUND: [¹⁸F]-6-thia-14-fluoro-heptadecanoic acid 3b, a free fatty acid, has been used in myocardial PET imaging. In order to establish an automated synthesis module for routine production in the country, a study was performed for optimization of the production conditions as well as making modifications.
MATERIAL AND METHODS: [¹⁸F]Benzyl-14-Fluoro-6-thia-heptadecanoate 2b was prepared in no-carrier-added (n.c.a) form from Benzyl-14-tosyloxy-6-thia-heptadecanoate 1 in one step at 90°C in Kryptofix2.2.2/[¹⁸F] with acetonitrile as the solvent followed by Silica column chromatography. The radiolabelled ester 2 was then hydrolysed to yield [¹⁸F]-6-thia-14-fluoro-heptadecanoic 3b. The final solution was concentrated using the C₁₈ SPE system and administered to normal rats for biodistribution and co-incidence imaging studies.
RESULTS: The synthesis took 15 min with overall radiochemical yield of 15-25% (EOS) and chemical-radiochemical purity of more than 90%. Automation was performed using a two-pot synthesis. The best imaging time was shown to be 140-180 minutes post injection.
CONCLUSIONS: Using this procedure a fast, reliable, automated synthesis for the cardial PET tracer, i.e. [¹⁸F]FTHA, can be obtained without an HPLC purification step.